TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis C$0.23 -0.03 (-9.80%) As of 02:07 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Microbix Biosystems Stock (TSE:MBX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Microbix Biosystems alerts:Sign Up Key Stats Today's RangeC$0.22▼C$0.2450-Day RangeC$0.23▼C$0.2752-Week RangeC$0.21▼C$0.36Volume452,519 shsAverage Volume60,986 shsMarket CapitalizationC$31.87 millionP/E RatioN/ADividend Yield2.30%Price TargetN/AConsensus RatingN/A Company Overview Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. Read More Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Stock News HeadlinesMicrobix Biosystems Inc.: Microbix Schedules Release of Results for Q2 Fiscal 2026May 8, 2026 | finanznachrichten.deMicrobix Schedules Release of Results for Q2 Fiscal 2026May 8, 2026 | finance.yahoo.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 14 at 1:00 AM | Porter & Company (Ad)Microbix Biosystems Inc.: Microbix Product Results Being Presented at 2026 PASCVApril 27, 2026 | finanznachrichten.deMicrobix Product Results Being Presented at 2026 PASCVApril 27, 2026 | finance.yahoo.comMicrobix Presenting at the 2026 Bloom Burton ConferenceApril 16, 2026 | theglobeandmail.comMicrobix to Court Global Healthcare Investors at 2026 Bloom Burton ConferenceApril 16, 2026 | tipranks.comMicrobix Biosystems Inc.: Microbix Exhibiting & Presenting at ESCMID Global 2026April 15, 2026 | finanznachrichten.deSee More Headlines MBX Stock Analysis - Frequently Asked Questions How have MBX shares performed this year? Microbix Biosystems' stock was trading at C$0.23 at the start of the year. Since then, MBX shares have decreased by 4.3% and is now trading at C$0.22. How were Microbix Biosystems' earnings last quarter? Microbix Biosystems Inc. (TSE:MBX) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $3.38 million for the quarter. Microbix Biosystems had a negative net margin of 25.48% and a negative trailing twelve-month return on equity of 14.88%. Read the conference call transcript. How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), Organigram (OGI), VEON (VEON) and Company Calendar Today5/14/2026Last Earnings5/14/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.03) Trailing P/E RatioN/A Forward P/E Ratio11.50 P/E GrowthN/ANet IncomeC$3.39 million Net Margins-25.48% Pretax MarginN/A Return on Equity-14.88% Return on Assets3.82% Debt Debt-to-Equity Ratio30.47 Current Ratio7.51 Quick Ratio5.57 Sales & Book Value Annual SalesC$16.76 million Price / Sales1.90 Cash FlowC$0.06 per share Price / Cash Flow4.13 Book ValueC$0.19 per share Price / Book1.20Miscellaneous Outstanding Shares138,553,000Free FloatN/AMarket CapC$31.87 million OptionableNot Optionable Beta0.48 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (TSE:MBX) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersOne coin wired into Elon's visionThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...Crypto 101 Media | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredTengu is coming (prepare for June 16)A data leak exposed the code name of an AI breakthrough called Project Tengu - and in just six days, it erased...Chaikin Analytics | SponsoredThe system holding the dollar together is gone…Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
